Hims & Hers Health, Inc. Fundamental Analysis
Hims & Hers Health, Inc. (HIMS) shows weak financial fundamentals with a PE ratio of -688.20, profit margin of -0.56%, and ROE of -2.48%. The company generates $2.3B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 7.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze HIMS's fundamental strength across five key dimensions:
Efficiency Score
WeakHIMS struggles to generate sufficient returns from assets.
Valuation Score
ModerateHIMS shows balanced valuation metrics.
Growth Score
WeakHIMS faces weak or negative growth trends.
Financial Health Score
ModerateHIMS shows balanced financial health with some risks.
Profitability Score
WeakHIMS struggles to sustain strong margins.
Key Financial Metrics
Is HIMS Expensive or Cheap?
P/E Ratio
HIMS trades at -688.20 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, HIMS's PEG of 6.45 indicates potential overvaluation.
Price to Book
The market values Hims & Hers Health, Inc. at 17.61 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 225.12 times EBITDA. This signals the market has high growth expectations.
How Well Does HIMS Make Money?
Net Profit Margin
For every $100 in sales, Hims & Hers Health, Inc. keeps $-0.56 as profit after all expenses.
Operating Margin
Core operations generate 1.32 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-2.48 in profit for every $100 of shareholder equity.
ROA
Hims & Hers Health, Inc. generates $-0.58 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Hims & Hers Health, Inc. produces operating cash flow of $277.11M, showing steady but balanced cash generation.
Free Cash Flow
Hims & Hers Health, Inc. produces free cash flow of $74.09M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.33 in free cash annually.
FCF Yield
HIMS converts 0.98% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-688.20
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
6.45
vs 25 benchmark
P/B Ratio
Price to book value ratio
17.61
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.24
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
2.54
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.69
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.02
vs 25 benchmark
ROA
Return on assets percentage
-0.01
vs 25 benchmark
ROCE
Return on capital employed
0.02
vs 25 benchmark
How HIMS Stacks Against Its Sector Peers
| Metric | HIMS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -688.20 | 29.54 | Better (Cheaper) |
| ROE | -2.48% | 416.00% | Weak |
| Net Margin | -0.56% | -11311.00% (disorted) | Weak |
| Debt/Equity | 2.54 | 0.77 | Weak (High Leverage) |
| Current Ratio | 1.69 | 5.05 | Neutral |
| ROA | -0.58% | -174.00% (disorted) | Weak |
HIMS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Hims & Hers Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation